Stine Clemmensen
Overview
Explore the profile of Stine Clemmensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smit M, Sander A, Ariaans M, Fougeroux C, Heinzel C, Fendel R, et al.
Lancet Microbe
. 2023 Jan;
4(3):e140-e148.
PMID: 36681093
Background: Capsid virus-like particles (cVLP) have proven safe and immunogenic and can be a versatile platform to counter pandemics. We aimed to clinically test a modular cVLP COVID-19 vaccine in...
2.
Prentoe J, Janitzek C, Velazquez-Moctezuma R, Soerensen A, Jorgensen T, Clemmensen S, et al.
NPJ Vaccines
. 2022 Nov;
7(1):148.
PMID: 36379958
Development of B-cell-based hepatitis C virus (HCV) vaccines that induce broadly neutralizing antibodies (bNAbs) is hindered by extensive sequence diversity and low immunogenicity of envelope glycoprotein vaccine candidates, most notably...
3.
Ruzzi F, Palladini A, Clemmensen S, Strobaek A, Buijs N, Domeyer T, et al.
Biomedicines
. 2022 Oct;
10(10).
PMID: 36289916
Vaccines are a promising therapeutic alternative to monoclonal antibodies against HER-2+ breast cancer. We present the preclinical activity of an ES2B-C001, a VLP-based vaccine being developed for human breast cancer...
4.
Fougeroux C, Goksoyr L, Idorn M, Soroka V, Myeni S, Dagil R, et al.
Nat Commun
. 2021 Jan;
12(1):324.
PMID: 33436573
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. RBD...
5.
Thrane S, Janitzek C, Matondo S, Resende M, Gustavsson T, Adriaan de Jongh W, et al.
J Nanobiotechnology
. 2016 Apr;
14:30.
PMID: 27117585
Background: Virus-like particles (VLPs) represent a significant advance in the development of subunit vaccines, combining high safety and efficacy. Their particulate nature and dense repetitive subunit organization makes them ideal...
6.
Precht Jensen E, Clemmensen S, Bjorndal K, Krogdahl A
Ugeskr Laeger
. 2011 Feb;
173(5):353-4.
PMID: 21276400
Zygomycosis is an invasive and increasingly emerging life-threatening infection. Diabetes is the most common risk factor; however, zygomycosis has increased among patients with haematologic malignancy, which is now the second...